FIGURE

Fig. 4

ID
ZDB-FIG-220725-58
Publication
Holm et al., 2022 - The evolutionarily conserved miRNA-137 targets the neuropeptide hypocretin/orexin and modulates the wake to sleep ratio
Other Figures
All Figure Page
Back to All Figure Page
Fig. 4

Targeted downregulation of miR-137 in Hcrt neurons consolidates wakefulness. (A) Schematic representation of local injection of AAVs in the lateral hypothalamus of Hcrt:IRES-Cre driver mice. (B) Expression levels of Hcrt in murine brain after rAAV-anti-miR-137, rAAV-anti-miR-665, and rAAV-anti-miR-128 overexpression, specifically in the Hcrt-producing neurons. rAAV-anti-miR-128 was used as a control, as it does not target Hcrt. Mice were euthanized at 5 wk postinjection. Differences between the anti-miR and control groups were analyzed using a one-way ANOVA with Dunnett’s post hoc test. *P = 0.039. (n:  control = 5; anti-miR-137 = 5; anti-miR-665 = 6 animals). (C and D) Quantification of vigilance states per 4-h intervals over 24 h. Local expression of anti-miR-137 in Hcrt neurons increases wakefulness (C) and accordingly decreases NREM sleep (D), compared with control mice during the first 4 h of the dark period (ZT12-16). There is a significant increase of 24.1 ± 9.9% in the duration of wakefulness and a reduction of 56.4 ± 22.3% in that of NREM sleep, in anti-miR-137-injected animals during ZT12-16 (anti-miR-137 vs. control: *P < 0.05 for wakefulness and NREM; anti-miR-665 vs. control: P > 0.05 for wakefulness and NREM; one-way ANOVA with Dunnett’s post hoc test. n:  control = 7; anti-miR-137 = 5; anti-miR-665 = 6 animals). (E) Distribution of wakefulness bout durations shows significantly longer bouts in anti-miR-137–injected animals compared with controls during ZT12-16 (anti-miR-137 vs. control: **P < 0.01 for 4- to 8-s bouts of wakefulness; *P < 0.05 for >512-s bouts; two-way ANOVA with Dunnett’s post hoc test. n:  control = 7; anti-miR-137 = 5; anti-miR-665 = 6 animals). (F) Dynamics of NREM delta (0.75 to 4 Hz) power over 24 h indicates a tendency that anti-miR-137–injected animals have higher EEG delta power (22.8 ± 8.5) in the first percentile of NREM sleep during the dark period compared with controls (anti-miR-137 vs. control: P = 0.063; anti-miR-665 vs. control: P > 0.05; one-way ANOVA with Dunnett’s post hoc test. n: control = 7; anti-miR-137 = 5; anti-miR-665 = 6 animals).

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Proc. Natl. Acad. Sci. USA